Five-Year Intra-Arterial Evaluation After Fluoropolymer-Based Drug-Eluting Stent Implantation for a Superficial Femoral Artery

An 80-year-old man with dyslipidemia and smoking complained of right life-disabling claudication due to lesions in the middle part of the superficial femoral artery and was successfully treated by implantation of a 7.0×150-mm Eluvia.Five years after Eluvia implantation, claudication recurred under continuation of dual antiplatelet therapy.A lthough previous trials reported that Eluvia (Boston Scientific, Marlborough, MA, USA), a fluoropolymer-based drug-eluting stent, achieves durable patency in the treatment of femoropopliteal lesions, 1 there are no long-term investigations on the sustainability of this stent's performance.